KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Current Assets (2016 - 2026)

Teladoc Health's Current Assets history spans 13 years, with the latest figure at $1.1 billion for Q1 2026.

  • On a quarterly basis, Current Assets fell 29.31% to $1.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 29.31% decrease, with the full-year FY2025 number at $1.1 billion, down 32.74% from a year prior.
  • Current Assets hit $1.1 billion in Q1 2026 for Teladoc Health, up from $1.1 billion in the prior quarter.
  • Over the last five years, Current Assets for TDOC hit a ceiling of $1.7 billion in Q4 2024 and a floor of $1.1 billion in Q2 2025.
  • Historically, Current Assets has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
  • Biggest five-year swings in Current Assets: grew 17.09% in 2024 and later crashed 32.74% in 2025.
  • Tracing TDOC's Current Assets over 5 years: stood at $1.3 billion in 2022, then grew by 13.2% to $1.5 billion in 2023, then grew by 11.74% to $1.7 billion in 2024, then crashed by 32.74% to $1.1 billion in 2025, then grew by 1.18% to $1.1 billion in 2026.
  • Business Quant data shows Current Assets for TDOC at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.